Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review

Firas Ajam; Swapnil Patel; Anas Alrefaee; Dawn Calderon; Mohammad A. Hossain; Arif Asif

doi:doi:10.11648/j.ajim.20190701.16

| Peer-Reviewed

Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review

Firas Ajam, Swapnil Patel, Anas Alrefaee, Dawn Calderon, Mohammad A. Hossain, Arif Asif

Published in American Journal of Internal Medicine (Volume 7, Issue 1)

Received: 15 February 2019 Accepted: 25 March 2019 Published: 22 April 2019

Views: Downloads:

Download PDF

Share This Article

Twitter
Linked In
Facebook

Abstract

Cardiovascular diseases remains one of the leading causes of mortality worldwide, and causes more than one millions deaths annually in the United States alone. Patients with chronic kidney disease (CKD) are predisposed to different types of heart rhythm abnormalities including but not limited to atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation. Both cardiovascular diseases and chronic kidney disease (CKD) may cause various variations in the cardiovascular system, autonomic nervous system, and various electrolytes abnormalities that open the door for the occurrence of multiple cardiac arrhythmias. Various pathophysiological mechanisms have been suggested in describing the correlation of cardiac arrhythmias in CKD patients. Despite the substantial progress in the management of chronic kidney disease, cardiovascular complications still highly dominant in CKD patient. Thus, reducing mortality from cardiovascular disease and sudden cardiac death in dialysis is a global health challenge. Management of cardiac arrhythmias includes the use of antiarrhythmic drugs, in addition to the use of catheter ablation and cardiac implantable electronic devices. The present review addresses the correlation between chronic kidney disease and different cardiac arrhythmias, the different pathophysiological mechanisms explaining the high risk of arrhythmias in CKD patients, the diagnostic tools used to identify arrhythmias, and the rule of subcutaneous defibrillators in preventing sudden cardiac death in dialysis patients.

Published in	American Journal of Internal Medicine (Volume 7, Issue 1)
DOI	10.11648/j.ajim.20190701.16
Page(s)	22-26
Creative Commons	This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited.
Copyright	Copyright © The Author(s), 2019. Published by Science Publishing Group

Keywords

Cardiac Arrhythmia, Chronic Kidney Disease, Cardiovascular Disease, Cardiac Death

References

[1]	Zheng, Z., Croft, J. B., Giles, W. H., & Mensah, G. A. (2001). Sudden Cardiac Death in the United States, 1989 to 1998. Circulation, 104(18), 2158-2163. doi:10.1161/hc4301.098254.
[2]	Wanner, C., Herzog, C. A., Turakhia, M. P., Blankestijn, P. J., Carrero, J., Clase, C. M., Winkelmayer, W. C. (2018). Chronic kidney disease and arrhythmias: Highlights from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference. Kidney International, 94(2), 231-234. doi:10.1016/j.kint.2018.05.005.
[3]	Roberts, P. R., & Green, D. (2011). Arrhythmias in chronic kidney disease. Heart, 97(9), 766-773. doi:10.1136/hrt.2010.208587.
[4]	US Renal Data System 2015 Annual Data Report: Epidemiology of Kidney Disease in the United States. (2016). American Journal of Kidney Diseases, 67(3). doi:10.1053/j.ajkd.2015.12.015.
[5]	Bonato, F. O., & Canziani, M. E. (2017). Ventricular arrhythmia in chronic kidney disease patients. Jornal Brasileiro De Nefrologia, 39(2). doi:10.5935/0101-2800.20170033.
[6]	"Heart Disease Other Related Conditions". cdc.gov. September 3, 2014. Archived from the original on 14 February 2015. Retrieved 19 February 2015.
[7]	Sodickson, A., & Urman, R. D. (n.d.). Opioids. Essential Clinical Anesthesia Review, 133-136. doi:10.1017/cbo9781139584005.038.
[8]	Sawhney, N. S., Anousheh, R., Chen, W., & Feld, G. K. (2009). Diagnosis and Management of Typical Atrial Flutter. Cardiology Clinics, 27(1), 55-67. doi:10.1016/j.ccl.2008.09.010.
[9]	"Types of Arrhythmia". NHLBI. July 1, 2011. Archived from the original on 7 June 2015. Retrieved 7 September 2016.
[10]	"What Is Sudden Cardiac Arrest?". NHLBI. June 22, 2016. Archived from the original on 28 July 2016. Retrieved 16 August 2016.
[11]	Chugh, S. S., Kelly, K. L., & Titus, J. L. (2000). Sudden Cardiac Death With Apparently Normal Heart. Circulation, 102(6), 649-654. doi:10.1161/01.cir.102.6.649.
[12]	Lullo, L. D., Gorini, A., Russo, D., Santoboni, A., & Ronco, C. (2015). Left Ventricular Hypertrophy in Chronic Kidney Disease Patients: From Pathophysiology to Treatment. Cardiorenal Medicine, 5(4), 254-266. doi:10.1159/000435838.
[13]	Go, A., Chertow, G., Fan, D., Mcculloch, C., & Hsu, C. (2004). Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization. ACC Current Journal Review, 13(12), 13. doi:10.1016/j.accreview.2004.11.016.
[14]	Zachariah, D., Kalra, P. R., & Roberts, P. R. (2014). Sudden cardiac death in end stage renal disease: Unlocking the mystery. Journal of Nephrology, 28(2), 133-141. Doi: 10.1007/s40620-014-0151-3.
[15]	Kiuchi, M. G., Chen, S., & Pürerfellner, H. (2017). Incidence of ventricular arrhythmic events in CKD patients with ICD. International Journal of Cardiology, 227, 312-317. doi:10.1016/j.ijcard.2016.11.094.
[16]	Hsueh, C., Chen, N. X., Lin, S., Chen, P., Gattone, V. H., Allen, M. R. Moe, S. M. (2014). Pathogenesis of Arrhythmias in a Model of CKD. Journal.
[17]	Cai, Q., Mukku, V., & Ahmad, M. (2014). Coronary Artery Disease in Patients with Chronic Kidney Disease: A Clinical Update. Current Cardiology Reviews, 9(4), 331-339. Doi: 10.2174/1573403x10666140214122234.
[18]	Ryan, M. (2014). Faculty of 1000 evaluation for Fibroblast Growth Factor-23 and Incident Atrial Fibrillation: The Multi-Ethnic Study of Atherosclerosis (MESA) and the Cardiovascular Health Study (CHS). F1000 - Post-publication Peer Review of the Biomedical Literature. doi:10.3410/f.718447086.793497545.
[19]	Dikow, R. (2004). Increased Infarct Size in Uremic Rats: Reduced Ischemia Tolerance? Journal of the American Society of Nephrology, 15(6), 1530-1536. doi:10.1097/01.asn.0000130154.42061.c6.
[20]	Chen PS, Chou CC, Tan AY, Zhou S, Fishbein MC, Hwang C, Karagueuzian HS, Lin SF. The mechanisms of atrial fibrillation. J Cardiovasc Electrophysiol. 2006 Dec; 17 Suppl 3:S2-7.
[21]	Ritz, E., & Wanner, C. (2008). The Challenge of Sudden Death in Dialysis Patients. Clinical Journal of the American Society of Nephrology, 3(3), 920-929. doi:10.2215/cjn.04571007.
[22]	Shafi, S., Saleem, M., Anjum, R., Abdullah, W., & Shafi, T. (n.d.). ECG Abnormalities In Patients With chronic kidney disease. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/28712176.
[23]	Huang, J., Wei, S., Chen, S., Chang, J., Hung, C., Su, H. Chen, H. (2014). P Wave Dispersion and Maximum P Wave Duration Are Associated with Renal Outcomes in Chronic Kidney Disease. PLoS ONE, 9(7). doi:10.1371/journal.pone.0101962.
[24]	Huang, Y., Chang, Y., Chen, I., Yang, C., Leu, S., Su, H., Shiao, C. (2017). Correction: Heart rate variability during hemodialysis is an indicator for long-term vascular access survival in uremic patients. Plos One, 12(7). doi:10.1371/journal.pone.0181283.
[25]	Thomson, B. J., Mcareavey, D., Neilson, J. M., Winney, R. J., & Ewing, D. J. (1991). Heart rate variability and cardiac arrhythmias in patients with chronic renal failure. Clinical Autonomic Research, 1(2), 131-133. doi:10.1007/bf01826209.
[26]	The role of echocardiographic study in patients with chronic kidney disease. (2015, July 15). Retrieved from http://www.sciencedirect.com/science/article/pii/S0929664615002326.
[27]	Korzets, A., Ori, Y., & Herman, M. (2001, May). Serum potassium levels and atrial fibrillation in haemodialysis patients. Retrieved from https://www.ncbi.nlm.nih.gov/pubmed/11328938.
[28]	Serum potassium levels and the risk of atrial fibrillation: The Rotterdam Study. (2013, August 23). Retrieved from https://www.sciencedirect.com/science/article/pii/S0167527313015982.
[29]	Roy-Chaudhury, P., Tumlin, J. A., Koplan, B. A., Costea, A. I., Kher, V., Williamson, D., Winkelmayer, W. C. (2018). Primary outcomes of the Monitoring in Dialysis Study indicate that clinically significant arrhythmias are common in hemodialysis patients and related to dialytic cycle. Kidney International, 93(4), 941-951. doi:10.1016/j.kint.2017.11.019.
[30]	Bleyer, A., Hartman, J., Brannon, P., Reeves-Daniel, A., Satko, S., & Russell, G. (2006). Characteristics of sudden death in hemodialysis patients. Kidney International, 69(12), 2268-2273. doi:10.1038/sj.ki.5000446.
[31]	Bakris, G. L., Pitt, B., Weir, M. R., Freeman, M. W., Mayo, M. R., Garza, D. Bushinsky, D. A. (2015). Effect of Patiromer on Serum Potassium Level in Patients With Hyperkalemia and Diabetic Kidney Disease. Jama, 314(2), 151. doi:10.1001/jama.2015.7446.
[32]	Vachharajani, T. J., Salman, L., Costanzo, E. J., Mehandru, S. K., Patel, M., Calderon, D. M. Asif, A. (2017). Subcutaneous defibrillators for dialysis patients. Hemodialysis International, 22(1), 4-8. doi:10.1111/hdi.12577.
[33]	Carrillo, R. G., Garisto, J. D., Salman, L., Merrill, D., & Asif, A. (2010). Contamination of Transvenous Pacemaker Leads Due to Tunneled Hemodialysis Catheter Infection: A Report of 2 Cases. American Journal of Kidney Diseases, 55(6), 1097-1101. doi:10.1053/j.ajkd.2010.01.009.

Cite This Article

Plain Text BibTeX RIS

APA Style

Firas Ajam, Swapnil Patel, Anas Alrefaee, Dawn Calderon, Mohammad A. Hossain, et al. (2019). Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review. American Journal of Internal Medicine, 7(1), 22-26. https://doi.org/10.11648/j.ajim.20190701.16

Copy | Download

ACS Style

Firas Ajam; Swapnil Patel; Anas Alrefaee; Dawn Calderon; Mohammad A. Hossain, et al. Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review. Am. J. Intern. Med. 2019, 7(1), 22-26. doi: 10.11648/j.ajim.20190701.16

Copy | Download

AMA Style

Firas Ajam, Swapnil Patel, Anas Alrefaee, Dawn Calderon, Mohammad A. Hossain, et al. Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review. Am J Intern Med. 2019;7(1):22-26. doi: 10.11648/j.ajim.20190701.16

Copy | Download

@article{10.11648/j.ajim.20190701.16,
  author = {Firas Ajam and Swapnil Patel and Anas Alrefaee and Dawn Calderon and Mohammad A. Hossain and Arif Asif},
  title = {Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review},
  journal = {American Journal of Internal Medicine},
  volume = {7},
  number = {1},
  pages = {22-26},
  doi = {10.11648/j.ajim.20190701.16},
  url = {https://doi.org/10.11648/j.ajim.20190701.16},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20190701.16},
  abstract = {Cardiovascular diseases remains one of the leading causes of mortality worldwide, and causes more than one millions deaths annually in the United States alone. Patients with chronic kidney disease (CKD) are predisposed to different types of heart rhythm abnormalities including but not limited to atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation. Both cardiovascular diseases and chronic kidney disease (CKD) may cause various variations in the cardiovascular system, autonomic nervous system, and various electrolytes abnormalities that open the door for the occurrence of multiple cardiac arrhythmias. Various pathophysiological mechanisms have been suggested in describing the correlation of cardiac arrhythmias in CKD patients. Despite the substantial progress in the management of chronic kidney disease, cardiovascular complications still highly dominant in CKD patient. Thus, reducing mortality from cardiovascular disease and sudden cardiac death in dialysis is a global health challenge. Management of cardiac arrhythmias includes the use of antiarrhythmic drugs, in addition to the use of catheter ablation and cardiac implantable electronic devices. The present review addresses the correlation between chronic kidney disease and different cardiac arrhythmias, the different pathophysiological mechanisms explaining the high risk of arrhythmias in CKD patients, the diagnostic tools used to identify arrhythmias, and the rule of subcutaneous defibrillators in preventing sudden cardiac death in dialysis patients.},
 year = {2019}
}

Copy | Download

TY  - JOUR
T1  - Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review
AU  - Firas Ajam
AU  - Swapnil Patel
AU  - Anas Alrefaee
AU  - Dawn Calderon
AU  - Mohammad A. Hossain
AU  - Arif Asif
Y1  - 2019/04/22
PY  - 2019
N1  - https://doi.org/10.11648/j.ajim.20190701.16
DO  - 10.11648/j.ajim.20190701.16
T2  - American Journal of Internal Medicine
JF  - American Journal of Internal Medicine
JO  - American Journal of Internal Medicine
SP  - 22
EP  - 26
PB  - Science Publishing Group
SN  - 2330-4324
UR  - https://doi.org/10.11648/j.ajim.20190701.16
AB  - Cardiovascular diseases remains one of the leading causes of mortality worldwide, and causes more than one millions deaths annually in the United States alone. Patients with chronic kidney disease (CKD) are predisposed to different types of heart rhythm abnormalities including but not limited to atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation. Both cardiovascular diseases and chronic kidney disease (CKD) may cause various variations in the cardiovascular system, autonomic nervous system, and various electrolytes abnormalities that open the door for the occurrence of multiple cardiac arrhythmias. Various pathophysiological mechanisms have been suggested in describing the correlation of cardiac arrhythmias in CKD patients. Despite the substantial progress in the management of chronic kidney disease, cardiovascular complications still highly dominant in CKD patient. Thus, reducing mortality from cardiovascular disease and sudden cardiac death in dialysis is a global health challenge. Management of cardiac arrhythmias includes the use of antiarrhythmic drugs, in addition to the use of catheter ablation and cardiac implantable electronic devices. The present review addresses the correlation between chronic kidney disease and different cardiac arrhythmias, the different pathophysiological mechanisms explaining the high risk of arrhythmias in CKD patients, the diagnostic tools used to identify arrhythmias, and the rule of subcutaneous defibrillators in preventing sudden cardiac death in dialysis patients.
VL  - 7
IS  - 1
ER  -

Copy | Download

Author Information

Firas Ajam

Department of Medicine, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, USA
Swapnil Patel

Department of Medicine, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, USA
Anas Alrefaee

Department of Medicine, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, USA
Dawn Calderon

Department of Cardiology, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, USA
Mohammad A. Hossain

Department of Medicine, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, USA
Arif Asif

Department of Medicine, Jersey Shore University Medical Center, Hackensack Meridian Health, Neptune, USA

Download PDF

Sections

Plain Text BibTeX RIS

APA Style

Firas Ajam, Swapnil Patel, Anas Alrefaee, Dawn Calderon, Mohammad A. Hossain, et al. (2019). Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review. American Journal of Internal Medicine, 7(1), 22-26. https://doi.org/10.11648/j.ajim.20190701.16

Copy | Download

ACS Style

Firas Ajam; Swapnil Patel; Anas Alrefaee; Dawn Calderon; Mohammad A. Hossain, et al. Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review. Am. J. Intern. Med. 2019, 7(1), 22-26. doi: 10.11648/j.ajim.20190701.16

Copy | Download

AMA Style

Firas Ajam, Swapnil Patel, Anas Alrefaee, Dawn Calderon, Mohammad A. Hossain, et al. Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review. Am J Intern Med. 2019;7(1):22-26. doi: 10.11648/j.ajim.20190701.16

Copy | Download

@article{10.11648/j.ajim.20190701.16,
  author = {Firas Ajam and Swapnil Patel and Anas Alrefaee and Dawn Calderon and Mohammad A. Hossain and Arif Asif},
  title = {Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review},
  journal = {American Journal of Internal Medicine},
  volume = {7},
  number = {1},
  pages = {22-26},
  doi = {10.11648/j.ajim.20190701.16},
  url = {https://doi.org/10.11648/j.ajim.20190701.16},
  eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ajim.20190701.16},
  abstract = {Cardiovascular diseases remains one of the leading causes of mortality worldwide, and causes more than one millions deaths annually in the United States alone. Patients with chronic kidney disease (CKD) are predisposed to different types of heart rhythm abnormalities including but not limited to atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation. Both cardiovascular diseases and chronic kidney disease (CKD) may cause various variations in the cardiovascular system, autonomic nervous system, and various electrolytes abnormalities that open the door for the occurrence of multiple cardiac arrhythmias. Various pathophysiological mechanisms have been suggested in describing the correlation of cardiac arrhythmias in CKD patients. Despite the substantial progress in the management of chronic kidney disease, cardiovascular complications still highly dominant in CKD patient. Thus, reducing mortality from cardiovascular disease and sudden cardiac death in dialysis is a global health challenge. Management of cardiac arrhythmias includes the use of antiarrhythmic drugs, in addition to the use of catheter ablation and cardiac implantable electronic devices. The present review addresses the correlation between chronic kidney disease and different cardiac arrhythmias, the different pathophysiological mechanisms explaining the high risk of arrhythmias in CKD patients, the diagnostic tools used to identify arrhythmias, and the rule of subcutaneous defibrillators in preventing sudden cardiac death in dialysis patients.},
 year = {2019}
}

Copy | Download

TY  - JOUR
T1  - Cardiac Arrhythmias in Patients with End Stage Renal Disease (ESRD) on Hemodialysis; Recent Update and Brief Literature Review
AU  - Firas Ajam
AU  - Swapnil Patel
AU  - Anas Alrefaee
AU  - Dawn Calderon
AU  - Mohammad A. Hossain
AU  - Arif Asif
Y1  - 2019/04/22
PY  - 2019
N1  - https://doi.org/10.11648/j.ajim.20190701.16
DO  - 10.11648/j.ajim.20190701.16
T2  - American Journal of Internal Medicine
JF  - American Journal of Internal Medicine
JO  - American Journal of Internal Medicine
SP  - 22
EP  - 26
PB  - Science Publishing Group
SN  - 2330-4324
UR  - https://doi.org/10.11648/j.ajim.20190701.16
AB  - Cardiovascular diseases remains one of the leading causes of mortality worldwide, and causes more than one millions deaths annually in the United States alone. Patients with chronic kidney disease (CKD) are predisposed to different types of heart rhythm abnormalities including but not limited to atrial fibrillation, atrial flutter, ventricular tachycardia, and ventricular fibrillation. Both cardiovascular diseases and chronic kidney disease (CKD) may cause various variations in the cardiovascular system, autonomic nervous system, and various electrolytes abnormalities that open the door for the occurrence of multiple cardiac arrhythmias. Various pathophysiological mechanisms have been suggested in describing the correlation of cardiac arrhythmias in CKD patients. Despite the substantial progress in the management of chronic kidney disease, cardiovascular complications still highly dominant in CKD patient. Thus, reducing mortality from cardiovascular disease and sudden cardiac death in dialysis is a global health challenge. Management of cardiac arrhythmias includes the use of antiarrhythmic drugs, in addition to the use of catheter ablation and cardiac implantable electronic devices. The present review addresses the correlation between chronic kidney disease and different cardiac arrhythmias, the different pathophysiological mechanisms explaining the high risk of arrhythmias in CKD patients, the diagnostic tools used to identify arrhythmias, and the rule of subcutaneous defibrillators in preventing sudden cardiac death in dialysis patients.
VL  - 7
IS  - 1
ER  -

Copy | Download